TIPICO IX: report of the 9
TIPICO
infectious diseases
infectomics
vaccine hesitancy
vaccines
vaccinomics
Journal
Human vaccines & immunotherapeutics
ISSN: 2164-554X
Titre abrégé: Hum Vaccin Immunother
Pays: United States
ID NLM: 101572652
Informations de publication
Date de publication:
2019
2019
Historique:
pubmed:
4
6
2019
medline:
19
2
2020
entrez:
4
6
2019
Statut:
ppublish
Résumé
The Ninth Interactive Infectious Disease workshop TIPICO was held on November 22-23, 2018, in Santiago de Compostela, Spain. This 2-day academic experience addressed current and topical issues in the field of infectious diseases and vaccination. Summary findings of the meeting include: cervical cancer elimination will be possible in the future, thanks to the implementation of global vaccination action plans in combination with appropriate screening interventions. The introduction of appropriate immunization programs is key to maintain the success of current effective vaccines such as those against meningococcal disease or rotavirus infection. Additionally, reduced dose schedules might improve the efficiency of some vaccines (i.e., PCV13). New vaccines to improve current preventive alternatives are under development (e.g., against tuberculosis or influenza virus), while others to protect against infectious diseases with no current available vaccines (e.g., enterovirus, parechovirus and flaviviruses) need to be developed. Vaccinomics will be fundamental in this process, while infectomics will allow the application of precision medicine. Further research is also required to understand the impact of heterologous vaccine effects. Finally, vaccination requires education at all levels (individuals, community, healthcare professionals) to ensure its success by helping to overcome major barriers such as vaccine hesitancy and false contraindications.
Identifiants
pubmed: 31158041
doi: 10.1080/21645515.2019.1609823
pmc: PMC6816368
doi:
Substances chimiques
Vaccines
0
Types de publication
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
2405-2415Références
Vaccine. 2012 Jun 19;30(29):4301-6
pubmed: 22682286
Curr Opin Immunol. 2002 Feb;14(1):111-6
pubmed: 11790540
J Infect Dis. 2000 Feb;181 Suppl 1:S228-31
pubmed: 10657219
Clin Exp Vaccine Res. 2017 Jan;6(1):4-14
pubmed: 28168168
Bull World Health Organ. 1993;71(5):549-60
pubmed: 8261558
Eur J Pediatr. 2010 Nov;169(11):1379-86
pubmed: 20559656
J Infect Dis. 2014 Dec 1;210(11):1772-9
pubmed: 24939906
PLoS One. 2018 May 25;13(5):e0195799
pubmed: 29799839
Antiviral Res. 2009 Jan;81(1):6-15
pubmed: 18796313
Psychol Sci Public Interest. 2012 Dec;13(3):106-31
pubmed: 26173286
Trends Biotechnol. 2016 Apr;34(4):276-290
pubmed: 26806111
Lancet Infect Dis. 2015 May;15(5):535-43
pubmed: 25801458
Sci Rep. 2018 May 23;8(1):8043
pubmed: 29795312
Euro Surveill. 2016 Nov 10;21(45):
pubmed: 27918265
Nat Rev Immunol. 2011 Nov 04;11(12):865-72
pubmed: 22051890
J Virol. 2017 Jan 18;91(3):
pubmed: 27881649
Pediatrics. 2016 Feb;137(2):e20152848
pubmed: 26791970
Vaccine. 2015 Jun 26;33(29):3314-21
pubmed: 26026378
Arch Dis Child. 2017 Nov;102(11):1077-1081
pubmed: 28501809
Infect Drug Resist. 2019 Apr 29;12:989-991
pubmed: 31118704
Nature. 1992 Aug 6;358(6386):507-10
pubmed: 1386410
Vaccine. 2019 May 31;37(25):3362-3368
pubmed: 31064673
PLoS One. 2008;3(10):e3496
pubmed: 18946503
Funct Integr Genomics. 2002 Apr;1(6):331-44
pubmed: 11957108
Front Immunol. 2014 Jan 23;5:12
pubmed: 24478777
Clin Infect Dis. 2013 Jul;57(1):13-20
pubmed: 23487388
Sci Rep. 2016 Nov 02;6:35842
pubmed: 27805046
N Engl J Med. 2015 Mar 19;372(12):1114-25
pubmed: 25785969
JAMA. 2016 Aug 23-30;316(8):835-45
pubmed: 27552617
Tuberculosis (Edinb). 2016 Jan;96:71-4
pubmed: 26786657
Allergol Immunopathol (Madr). 2018 Jan - Feb;46(1):99-104
pubmed: 28495398
J Infect Dis. 2016 Jan 15;213(2):243-9
pubmed: 26232438
Thorax. 2012 Jan;67(1):71-9
pubmed: 20729232
Clin Infect Dis. 2015 Jan 15;60(2):228-36
pubmed: 25301212
Euro Surveill. 2016 Nov 17;21(46):
pubmed: 27918268
Pathogens. 2017 Dec 12;6(4):null
pubmed: 29231855
Lancet Glob Health. 2018 Sep;6(9):e1036-e1044
pubmed: 30103981
Lancet. 2016 Dec 3;388(10061):2775-2782
pubmed: 28100432
J Infect Chemother. 2017 Jul;23(7):419-426
pubmed: 28511987
Infect Dis Ther. 2016 Mar;5(1):31-44
pubmed: 26721823
J Infect Dis. 2017 Sep 1;216(5):525-533
pubmed: 28329234
Proc Natl Acad Sci U S A. 2014 Jan 7;111(1):125-30
pubmed: 24344259
Infect Genet Evol. 2016 Oct;44:403-411
pubmed: 27491455
Clin Infect Dis. 2018 Oct 30;67(10):1498-1506
pubmed: 29790925
Immunity. 2010 Oct 29;33(4):530-41
pubmed: 21029963
Proc Natl Acad Sci U S A. 2014 Jun 24;111(25):E2514-23
pubmed: 24927560
Eur J Pediatr. 2016 Aug;175(8):1023-9
pubmed: 27156106
Infect Drug Resist. 2018 Dec 24;12:55-64
pubmed: 30636886
Eur J Pediatr. 2018 Oct;177(10):1523-1529
pubmed: 30022279
Clin Infect Dis. 2014 Jan;58(2):181-7
pubmed: 24149079
BMC Infect Dis. 2016 Nov 7;16(1):645
pubmed: 27821085
OMICS. 2011 Sep;15(9):625-36
pubmed: 21732819
Vaccine. 2015 Aug 14;33(34):4176-9
pubmed: 25896376
Curr Opin Virol. 2013 Oct;3(5):521-30
pubmed: 23978327
J Gen Virol. 1996 Jul;77 ( Pt 7):1483-7
pubmed: 8757990
Nat Commun. 2014 Aug 14;5:4649
pubmed: 25120092
Vaccine. 2017 Feb 1;35(5):716-721
pubmed: 28065475
J Exp Med. 1996 Apr 1;183(4):1623-31
pubmed: 8666920
Nat Commun. 2017 Jul 14;8:16085
pubmed: 28706226
Arch Inst Pasteur Madagascar. 1981;48(1):269-78
pubmed: 7044329
Lancet Public Health. 2019 Jan;4(1):e19-e27
pubmed: 30291040
Virol J. 2018 Jan 19;15(1):17
pubmed: 29370862
Vaccine. 2017 Sep 18;35(39):5264-5270
pubmed: 28823622
Vaccine. 2018 Aug 6;36(32 Pt A):4774-4782
pubmed: 29366703
Cell Host Microbe. 2018 May 9;23(5):672-685.e6
pubmed: 29746837
Pediatr Infect Dis J. 2018 May;37(5):475-482
pubmed: 29329168
Infect Dis (Lond). 2017 May;49(5):388-395
pubmed: 28067093
J Virol. 2012 Dec;86(24):13434-44
pubmed: 23015722
Sci Rep. 2017 Nov 21;7(1):15888
pubmed: 29162850
Nat Med. 2015 Sep;21(9):1065-70
pubmed: 26301691
Lancet Infect Dis. 2018 Feb;18(2):171-179
pubmed: 29174323
Nat Genet. 2010 Sep;42(9):772-6
pubmed: 20694013
Ann Am Thorac Soc. 2014 Aug;11 Suppl 4:S189-92
pubmed: 25148424
Eur J Pediatr. 2015 Jul;174(7):919-24
pubmed: 25573462
Clin Infect Dis. 2015 Jun 1;60(11):1611-9
pubmed: 25725054
Lancet Infect Dis. 2018 Aug;18(8):828-829
pubmed: 30064668
Lancet Glob Health. 2016 Jul;4(7):e453-63
pubmed: 27340003
Front Immunol. 2017 Sep 13;8:1134
pubmed: 28955344
MMWR Morb Mortal Wkly Rep. 2017 Nov 03;66(43):1192-1196
pubmed: 29095805
BMC Infect Dis. 2012 Sep 13;12:213
pubmed: 22974466
MBio. 2010 May 18;1(1):null
pubmed: 20689752
Lancet Respir Med. 2015 Dec;3(12):953-62
pubmed: 26598141
Enferm Infecc Microbiol Clin. 2018 Dec;36(10):648-656
pubmed: 29627126
Biochem Biophys Res Commun. 2017 Oct 28;492(4):587-596
pubmed: 28576494
Health Psychol. 2013 Feb;32(2):146-55
pubmed: 22409264
Science. 2015 Sep 18;349(6254):1301-6
pubmed: 26303961
J Infect. 2014 Oct;69(4):326-32
pubmed: 24887614
Proc Natl Acad Sci U S A. 2012 Oct 23;109(43):17537-42
pubmed: 22988082
PLoS Negl Trop Dis. 2015 Nov 06;9(11):e0004177
pubmed: 26545242
Nat Rev Immunol. 2012 Jul 13;12(8):581-91
pubmed: 22790178
Lancet Infect Dis. 2014 Sep;14(9):839-46
pubmed: 25042756
JAMA Pediatr. 2018 Oct 1;172(10):958-965
pubmed: 30105384
Clin Infect Dis. 2015 Feb 15;60(4):578-85
pubmed: 25389259
Genes (Basel). 2018 May 03;9(5):null
pubmed: 29751582
Health Psychol. 2013 Apr;32(4):361-9
pubmed: 22059622
N Engl J Med. 2018 Oct 25;379(17):1621-1634
pubmed: 30280651
Lancet. 2015 Jul 4;386(9988):31-45
pubmed: 25913272
Front Microbiol. 2017 Mar 01;8:257
pubmed: 28298902
Vaccine. 2013 Oct 1;31(42):4867-73
pubmed: 23965219
Scand J Public Health. 2013 Dec;41(8):860-5
pubmed: 23873631
Res Immunol. 1993 Mar-Apr;144(3):209-13
pubmed: 8235045
J Exp Med. 2016 Apr 4;213(4):469-81
pubmed: 27022144
Curr Opin Virol. 2014 Apr;5:98-104
pubmed: 24727707
Vaccine. 2014 Dec 5;32(51):6870-6879
pubmed: 25444813
Cell Host Microbe. 2015 Jul 8;18(1):61-74
pubmed: 26159719
Euro Surveill. 2016 May 12;21(19):
pubmed: 27195770
Science. 1981 Jan 30;211(4481):453-8
pubmed: 7455683